Comments of the World Privacy Forum to the FTC re: Ingenix and Milliman FCRA enforcement action

Medical privacy — Some recent articles about the sale of patients’ prescription histories to insurance companies have raised many consumer questions about this practice. Ingenix and Milliman — two companies engaged in this practice — were the subject of a Federal Trade Commission enforcement action which was published for comment in September 2007. The World Privacy Forum provided formal comments to the Federal Trade Commission last year about this enforcement action; the WPF sought to have all affected consumers notified of adverse actions taken based on the information, and asked the FTC to modify its enforcement action to include an appropriate monetary penalty against the two companies.